Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mirati Therapeutics
(NQ:
MRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mirati Therapeutics
< Previous
1
2
3
4
5
6
7
8
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
May 08, 2023
Via
Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per...
Via
Benzinga
Why Shares of Zai Lab Soared This Week
January 05, 2023
A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company.
Via
The Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Mirati Therapeutics: Here's What You Need To Know
December 14, 2022
Via
Benzinga
Why Mirati Therapeutics Shares Are Nosediving
December 09, 2022
Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 4.90% to $41.70 after Citigroup downgraded the stock from Buy to Neutral.
Via
Benzinga
BMO Capital Downgrades Mirati Therapeutics: Here's What You Need To Know
December 08, 2022
Via
Benzinga
SKLZ Stock Alert: Will Skillz Shares Get Delisted?
December 22, 2022
Skillz (SKLZ) stock is worth checking on today as the company received a delisting notice from the New York Stock Exchange.
Via
InvestorPlace
Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today?
December 22, 2022
Chinese electric vehicle (EV) stocks are a chief concern among investors today as these shares see mixed trading on Thursday!
Via
InvestorPlace
Why Is ProQR (PRQR) Stock Up 83% Today?
December 22, 2022
ProQR (PRQR) stock is rising on Thursday thanks to an expanded licensing and collaboration agreement with Eli Lilly (LLY).
Via
InvestorPlace
Why Is Mirati Therapeutics (MRTX) Stock Up Today?
December 22, 2022
Mirati Therapeutics (MRTX) stock is rising on Thursday as investors react to a special designation from the FDA for adagrasib.
Via
InvestorPlace
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
December 15, 2022
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
What 10 Analyst Ratings Have To Say About Mirati Therapeutics
December 08, 2022
Via
Benzinga
Where Mirati Therapeutics Stands With Analysts
December 08, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Tesla To $235? Here Are 10 Other Price Target Changes For Wednesday
December 14, 2022
Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $305 to $235. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 0.4% to $160.35 in pre-market...
Via
Benzinga
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
December 13, 2022
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Via
Benzinga
Another Competitor For Amgen As FDA Approves Mirati Therapeutics' KRAS Inhibitor For Lung Cancer Setting
December 13, 2022
Via
Benzinga
Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
December 13, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. ACM Research, Inc. (NASDAQ: ACMR) shares jumped 25.9% to $10.98 in...
Via
Benzinga
Nasdaq, S&P 500 Futures Soar Amid Optimistic Expectations Concerning Nov. Inflation: Oracle, Tesla, Pinterest Among Early Movers
December 13, 2022
The index futures point to a modestly higher opening for the market on Tuesday, although the November consumer price inflation due ahead of the open could sway sentiment either way depending on how the...
Via
Benzinga
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
December 12, 2022
FDA action on its KRAS-blocking drug could help recently downtrodden Mirati.
Via
Investor's Business Daily
Why Mirati Therapeutics Stock Lost Half Its Value In Just Three Days
December 08, 2022
The company is still planning a Phase 3 study in non-small cell lung cancer.
Via
Investor's Business Daily
Why Mirati Therapeutics Shares Are Getting Hammered Again Today
December 08, 2022
Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 12.18% to $43.55 during Thursday's session after multiple analysts downgraded their ratings on the stock and lowered their price...
Via
Benzinga
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
December 08, 2022
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.
Via
Benzinga
Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday
December 08, 2022
U.S. stocks traded higher, with the Dow Jones jumping over 200 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
December 08, 2022
Via
Benzinga
Why Shares of Mirati Therapeutics Fell Wednesday
December 07, 2022
The company presented phase 2 data from its non-small cell lung cancer therapy.
Via
The Motley Fool
Why Mirati Therapeutics Stock Is Trading Sharply Lower Today
December 07, 2022
Mirati Therapeutics Inc (NASDAQ: MRTX) shares are trading lower by 29.32% to $50.55 on continued weakness after the company announced late-breaking results
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 07, 2022
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.